Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Most GLP-1 receptor agonists (except exenatide formulations) carry an FDA boxed warning regarding thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Prescription GLP-1 Medications (Wegovy, Ozempic, Zepbound): These are FDA-approved pharmaceutical products that have undergone extensive clinical trials demonstrating safety and efficacy
Kappe et al., 2013
Refill compliance remained higher among this segment due to minimal out-of-pocket expenses
US$ 27.53
US$ 29.46
US$ 20.70
US$ 23.88
US$ 24.25
US$ 20.58
US$ 22.78
